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Dear Editor,
We read with interest the informative article of Okada and
colleagues [1]. The authors evaluated the effect of nitroglycerin
on coronary vessel dimensions in patients who underwent
coronary computed tomographic (CT) angiography. We would
like to remind readers of several issues pertaining to the use of
radiation-based imaging techniques and iodinated contrast
material, either as performed in this study, or other studies in
the literature.
Nitroglycerin is a well-known and generally well-tolerated
vasodilator. As Okada and colleagues stated, administration of
sublingual nitroglycerin to enhance coronary vasodilatation is a
widely accepted procedure before coronary artery imaging such as
catheter angiography, intravascular ultrasound, as well as CT
angiography. The use of nitroglycerin immediately before coronary
CT angiography study has been reported to improve the diagnostic
accuracy of imaging in the literature [2]. However some radiologists
do not prefer nitroglycerin in their coronary CT angiography
protocols for different reasons such as due to the lack of necessity
or contraindication of the drug in some patients. Radiologists, as well
as Okada and colleagues, could prefer one of the two protocols (with
and without nitroglycerin) in their patients.
Coronary CT angiography is a feasible technique to decide
whether the patient has coronary artery disease. However, we
are confused about the usage of coronary CT angiography twice
in the same patient in this study. During a coronary CT
angiography a patient receives a radiation dose between 3 and
14 mSv [3]. In fact, the authors reported the total estimated
effective radiation dose of both scans to be about 28.2 mSv in this
study. It appears that about a half of this radiation dose is from
unnecessary second imaging. Although the patients did not
beneﬁt from the ﬁrst or second coronary CT angiography, they
were exposed to this radiation dose. Moreover, during the same
study, the patients received approximately 60 mL unnecessary
contrast material in the ﬁrst or second coronary CT angiography.
In fact, administration of medium iodinated (300 mgI/mL)
contrast material instead of a high iodinated contrast material
to decrease the total amount of contrast agent as done in this
study could also decrease the diagnostic accuracy of the coronary
CT angiography [4].
In conclusion, although there is no certain protocol about the
usage of nitroglycerin before coronary CT angiography, we think
that performing coronary CT angiography twice as described in this
study is unnecessary. Radiation-based imaging techniques should
be considered for patients likely to beneﬁt from the procedure and
not just for experimental purposes.0914-5087/ 2015 Japanese College of Cardiology. Published by Elsevier Ltd. All rightsReferences
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Author’s reply
Thank you for taking an interest in our study. We would like to
thank Dr Ersin Ozturk for raising some important points of
discussion regarding our recent publication in the Journal of
Cardiology [1].
I also think that performing coronary computed tomography
angiography (cCTA) twice in the same study is unnecessary as a
clinical use. However, our prospective study was designed to reserved.
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use of nitroglycerin in patients with atypical chest pain, especially
for the patients suspected of having spastic angina. This prospec-
tive study was approved by the local institutional review board as
‘‘Coronary CTA with/without nitroglycerin for evaluation of
coronary artery spasm’’.
Coronary spasm is one of the frequent causes of acute coronary
syndrome and should regularly be considered as a differential
diagnosis [2]. To diagnose coronary spasm, invasive provocation
tests have been performed [3,4], and acetylcholine (Ach) and
ergonovine tests are often used, because coronary arteries involved
in spasm are super-sensitive to ACh [3] and ergonovine [4].
Coronary arteries involved in spasm are reported to be highly
sensitive to nitrates and the attack of coronary artery spasm can
usually be promptly relieved by the sublingual administration or
oral spray of nitroglycerin or isosorbide dinitrate [5]. In our study,
hyper-reactivity of nitroglycerin was evaluated using cCTA
performed before and after the administration of nitroglycerin,
and coronary diameters were measured in each segment and
compared with each coronary diameter. As the baseline study, the
coronary vasodilation was compared with each coronary diameter.
This study was performed between August 2010 and November
2011 using ﬁrst-generation dual-source CT (Siemens SOMATOM
Deﬁnition, Erlangen, Germany), and unenhanced CT for measure-
ment of the coronary artery calcium scoring was omitted and
prospective electrocardiogram-dependent dose modulation was
used to reduce the radiation exposure. However, further patient
care is needed for radiation exposure.
The mean attenuation at major segments including segments
1–3, 5, 6, 7, 11 and 13 were 313.4  72.8 HU (before administration
of nitroglycerin) and 338.7  67.8 HU (after administration of
nitroglycerin) using intermediate (300 mgI/ml) iodine contrast
material and these attenuations presented a sufﬁcient attenuation
level to evaluate the coronary images in current study. Additional
contrast material increased mean attenuation and might affect the
image quality of cCTA after administration of nitroglycerin. A total of
contrast material ranged from 70 to 150 ml and varied according to
the patient’s body weight (41–78 kg) and heart rate and tolerant
volume of contrast material in usual systemic surveillance usingcontrast-enhanced CT. In this study, the patients with more than
moderate renal dysfunction were excluded and mean estimated
glomerular ﬁltration rate was 73.3  16.0 ml/min/1.73 m2. However,
we also paid attention to the patients’ renal function and reduced the
use of contrast material as much as possible.
I apologize for the lack of details about this prospective study
and I hope that my reply will address the problems that Dr Ersin
Ozturk raised. Once again, I would like to appreciate his intellectual
comments. I should be most grateful if I could continue to have
such a scientiﬁc discussion in future.
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